文献速递皮肤感染

中国头癣治疗的多中心前瞻性真实世界研究

Treatment of tinea capitis in China: A multicenter prospective real-world study.
PubMed 文献 · J Am Acad Dermatol · 2026-08-01

该研究在中国20家三级医院纳入819例头癣患者,分析病原学与不同口服抗真菌药疗效。最常见病原为犬小孢子菌(69.8%)。伊曲康唑(45.4%)与特比萘芬(33.4%)最常用,81.9%患者初始systemic治疗获临床治愈。灰斑型头癣中口服特比萘芬成功率(58.1%)显著低于伊曲康唑(92.2%)和氟康唑(91.3%),犬小孢子菌头癣特比萘芬成功率为59.4%。

要点

  • 中国头癣最常见病原为犬小孢子菌(69.8%)
  • 灰斑型头癣口服特比萘芬成功率(58.1%)低于伊曲康唑(92.2%)和氟康唑(91.3%)
  • 犬小孢子菌头癣特比萘芬治疗成功率仅59.4%,需关注

核心结论

  • 四种抗真菌药均显示良好疗效且耐受性良好,但需关注口服特比萘芬治疗灰斑型及犬小孢子菌头癣成功率相对较低。

主要发现

  • 最常见病原为犬小孢子菌(69.8%)。
  • 伊曲康唑(45.4%)和特比萘芬(33.4%)常用,灰黄霉素(16.0%)和氟康唑(5.3%)较少用。
  • 81.9%患者初始systemic抗真菌方案获临床治愈。
  • 灰斑型头癣中口服特比萘芬成功率(58.1%)显著低于伊曲康唑(92.2%)和氟康唑(91.3%)。
  • 犬小孢子菌头癣特比萘芬治疗成功率为59.4%。

关键数值与推荐

  • 灰斑型头癣:特比萘芬成功率58.1%,伊曲康唑92.2%,氟康唑91.3%。
  • 犬小孢子菌头癣:特比萘芬成功率59.4%。

临床怎么用

  • 治疗灰斑型头癣或犬小孢子菌所致头癣时,应优先考虑伊曲康唑或氟康唑而非特比萘芬。

局限性

  • 所有参与中心均为三级医院。
  • 数据缺失可能引入偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tinea capitis is still common in China. The gold standard for treatment is oral antifungal drugs. OBJECTIVE: This study aimed to clarify the current epidemiological characteristics and efficacy of different treatments of tinea capitis in China. METHODS: A multicenter, prospective real-world study involving 20 tertiary hospitals in China was conducted. From August 2020 to December 2021, 819 patients with tinea capitis were enrolled. Data concerning demography, clinical types, fungal tests, treatments and outcomes were analyzed. RESULTS: The most common pathogen was Microsporum canis (69.8%). Itraconazole (45.4%) and terbinafine (33.4%) were commonly used, while griseofulvin (16.0%) and fluconazole (5.3%) were less frequently prescribed. Most patients (81.9%) were clinically cured with the initial systemic antifungal treatment schemes. In treating gray patch tinea capitis, the success rate of oral terbinafine (58.1%) was significantly lower than itraconazole (92.2%) and fluconazole (91.3%). Treatment success rate of terbinafine for M canis tinea capitis was 59.4%. LIMITATIONS: All involved clinical centers are tertiary hospitals. Missing data may introduce bias. CONCLUSION: All 4 antifungal drugs have shown good efficacy and were well tolerated. More attention should be paid to the relatively low success rate of oral terbinafine in treating gray patch and M canis tinea capitis.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Chen XQ, Tong ZS, Ma L, et al. Treatment of tinea capitis in China: A multicenter prospective real-world study. J Am Acad Dermatol. 2026. PMID: 42542189. doi:10.1016/j.jaad.2026.07.100

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。